CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment

Clinical trial NCT07585760 · RECRUITING

Trial details

NCT number: NCT07585760
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma (MM)Multiple Myeloma Light Chain Induced Renal Insufficiency

Start date: 2026-07-25
Primary completion: 2028-05-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.